NewsVenture Capital23/07/2018
Gossamer Bio announces Series B preferred financing including Baupost
Baupost Group →Gossamer Bio announced a Series B preferred-stock financing led by Hillhouse Capital. Baupost participated as a new investor. Proceeds supported clinical development and business-development opportunities; no current stake is asserted.